Algorae Pharmaceuticals Limited LVCLY Stock
Algorae Pharmaceuticals Limited Price Chart
Algorae Pharmaceuticals Limited LVCLY Financial and Trading Overview
| Algorae Pharmaceuticals Limited stock price | 0.03 USD |
| Previous Close | 0.06 USD |
| Open | 0.07 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.07 - 0.07 USD |
| 52 Week Range | 0.03 - 0.09 USD |
| Volume | 15.4K USD |
| Avg. Volume | 1.42K USD |
| Market Cap | 16.27M USD |
| Beta (5Y Monthly) | 0.2659 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LVCLY Valuation Measures
| Enterprise Value | 4.11M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4778.257 |
| Price/Book (mrq) | 3.5950003 |
| Enterprise Value/Revenue | 1207.747 |
| Enterprise Value/EBITDA | -2.303 |
Trading Information
Algorae Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 0.2659 |
| 52-Week Change | 133.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.09 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.05 USD |
| 200-Day Moving Average | 0.06 USD |
LVCLY Share Statistics
| Avg. Volume (3 month) | 1.42K USD |
| Avg. Daily Volume (10-Days) | 4.9K USD |
| Shares Outstanding | 156.01M |
| Float | 93.27M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -52412.18% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.46% |
| Return on Equity (ttm) | -74.28% |
Income Statement
| Revenue (ttm) | 3.41K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 3.41K USD |
| EBITDA | -1785909 USD |
| Net Income Avi to Common (ttm) | -2529817 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.09M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.127 |
| Book Value Per Share (mrq) | 0.02 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2597148 USD |
| Levered Free Cash Flow (ttm) | -1138760 USD |
Profile of Algorae Pharmaceuticals Limited
| Country | United States |
| State | VIC |
| City | Melbourne |
| Address | Rialto South Tower |
| ZIP | 3000 |
| Phone | 61 3 8689 9997 |
| Website | https://www.lctglobal.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.
Q&A For Algorae Pharmaceuticals Limited Stock
What is a current LVCLY stock price?
Algorae Pharmaceuticals Limited LVCLY stock price today per share is 0.03 USD.
How to purchase Algorae Pharmaceuticals Limited stock?
You can buy LVCLY shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Algorae Pharmaceuticals Limited?
The stock symbol or ticker of Algorae Pharmaceuticals Limited is LVCLY.
Which industry does the Algorae Pharmaceuticals Limited company belong to?
The Algorae Pharmaceuticals Limited industry is Biotechnology.
How many shares does Algorae Pharmaceuticals Limited have in circulation?
The max supply of Algorae Pharmaceuticals Limited shares is 372.3M.
What is Algorae Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Algorae Pharmaceuticals Limited PE Ratio is 0.00000000 now.
What was Algorae Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Algorae Pharmaceuticals Limited EPS is 0 USD over the trailing 12 months.
Which sector does the Algorae Pharmaceuticals Limited company belong to?
The Algorae Pharmaceuticals Limited sector is Healthcare.